Literature DB >> 29400545

Ultrasound elastography as an imaging biomarker for detection of early tumor response to chemotherapy in a murine breast cancer model: a feasibility study.

Jian-Wei Wang1, Zhi-Xing Guo1, Qing-Guang Lin1, Wei Zheng1, Shu-Lian Zhuang2, Shi-Yang Lin1, An-Hua Li1, Xiao-Qing Pei1.   

Abstract

OBJECTIVE: This study investigated the feasibility of using strain elastography (SE) and real time shear wave elastography (RT-SWE) to evaluate early tumor response to cytotoxic chemotherapy in a murine xenograft breast cancer tumor model.
METHODS: MCF-7 breast cancer-bearing nude mice were treated with either cisplatin 2 mg kg-1 plus paclitaxel 10 mg kg-1 (treatment group) or sterile saline (control group) once daily for 5 days. The tumor elasticity was measured by SE or RT-SWE before and after therapy. Tumor cell density was assessed by hematoxylin and eosin staining, and the ratio of collagen fibers in the tumor was evaluated by Van Gieson staining. The correlation between tumor elasticity, as determined by SE and SWE, as well as the pathological tumor responses were analyzed.
RESULTS: Chemotherapy significantly attenuated tumor growth compared to the control treatment (p < 0.05). Chemotherapy also significantly increased tumor stiffness (p < 0.05) and significantly decreased (p < 0.05) tumor cell density compared with the control. Moreover, chemotherapy significantly increased the ratio of collagen fibers (p < 0.05). Tumor stiffness was positively correlated with the ratio of collagen fibers but negatively correlated with tumor cell density.
CONCLUSION: The study suggests that ultrasound elastography by SE and SWE is a feasible tool for assessing early responses of breast cancer to chemotherapy in our murine xenograft model. Advances in knowledge: This study showed that the tumor elasticity determined by ultrasound elastography could be a feasible imaging biomarker for assessing very early therapeutic responses to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29400545      PMCID: PMC6190766          DOI: 10.1259/bjr.20170698

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  21 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  On the effects of reflected waves in transient shear wave elastography.

Authors:  Thomas Deffieux; Jean-Luc Gennisson; Jeremy Bercoff; Mickael Tanter
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2011-10       Impact factor: 2.725

3.  Elastography: a quantitative method for imaging the elasticity of biological tissues.

Authors:  J Ophir; I Céspedes; H Ponnekanti; Y Yazdi; X Li
Journal:  Ultrason Imaging       Date:  1991-04       Impact factor: 1.578

Review 4.  WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 2: breast.

Authors:  Richard G Barr; Kazutaka Nakashima; Dominique Amy; David Cosgrove; Andre Farrokh; Fritz Schafer; Jeffrey C Bamber; Laurent Castera; Byung Ihn Choi; Yi-Hong Chou; Christoph F Dietrich; Hong Ding; Giovanna Ferraioli; Carlo Filice; Mireen Friedrich-Rust; Timothy J Hall; Kathryn R Nightingale; Mark L Palmeri; Tsuyoshi Shiina; Shinichi Suzuki; Ioan Sporea; Stephanie Wilson; Masatoshi Kudo
Journal:  Ultrasound Med Biol       Date:  2015-03-18       Impact factor: 2.998

5.  Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.

Authors:  Yan Ma; Shuo Zhang; Li Zang; Jing Li; Jianyi Li; Ye Kang; Weidong Ren
Journal:  Eur J Cancer       Date:  2016-11-04       Impact factor: 9.162

6.  Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography.

Authors:  Omar Falou; Ali Sadeghi-Naini; Sameera Prematilake; Ervis Sofroni; Naum Papanicolau; Sara Iradji; Zahra Jahedmotlagh; Sharon Lemon-Wong; Jean-Philippe Pignol; Eileen Rakovitch; Judit Zubovits; Jacqueline Spayne; Rebecca Dent; Maureen Trudeau; Jean Francois Boileau; Frances C Wright; Martin J Yaffe; Gregory J Czarnota
Journal:  Transl Oncol       Date:  2013-02-01       Impact factor: 4.243

7.  Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.

Authors:  Jian-Wei Wang; Wei Zheng; Ji-Bin Liu; Yao Chen; Long-Hui Cao; Rong-Zhen Luo; An-Hua Li; Jian-Hua Zhou
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

8.  Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?

Authors:  A Evans; S Armstrong; P Whelehan; K Thomson; P Rauchhaus; C Purdie; L Jordan; L Jones; A Thompson; S Vinnicombe
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

Review 9.  Practice guideline for the performance of breast ultrasound elastography.

Authors:  Su Hyun Lee; Jung Min Chang; Nariya Cho; Hye Ryoung Koo; Ann Yi; Seung Ja Kim; Ji Hyun Youk; Eun Ju Son; Seon Hyeong Choi; Shin Ho Kook; Jin Chung; Eun Suk Cha; Jeong Seon Park; Hae Kyoung Jung; Kyung Hee Ko; Hye Young Choi; Eun Bi Ryu; Woo Kyung Moon
Journal:  Ultrasonography       Date:  2013-11-26

Review 10.  Shear-wave elastography in breast ultrasonography: the state of the art.

Authors:  Ji Hyun Youk; Hye Mi Gweon; Eun Ju Son
Journal:  Ultrasonography       Date:  2017-04-05
View more
  1 in total

1.  Design and Demonstration of a Configurable Imaging Platform for Combined Laser, Ultrasound, and Elasticity Imaging.

Authors:  Heechul Yoon; Yiying I Zhu; Steven K Yarmoska; Stanislav Y Emelianov
Journal:  IEEE Trans Med Imaging       Date:  2018-12-27       Impact factor: 10.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.